Management of complicated parapneumonic effusions and thoracic empyema
- 11 July 2002
- journal article
- review article
- Published by Wiley in Internal Medicine Journal
- Vol. 32 (8), 408-414
- https://doi.org/10.1046/j.1445-5994.2002.00252.x
Abstract
The optimal management of loculated parapneumonic effusions and empyema includes breakdown of adhesions to effect drainage of infected pleural fluid. The use of fibrinolytics intrapleurally appears to enhance intercostal tube drainage, reducing the requirement for subsequent surgical mechanical debridement. This article discusses the evidence for intrapleural fibrinolytics, their good safety profile and the practicalities of dose and administration. It also reviews early surgical intervention, which may be indicated for medical treatment failure and, some would argue, as a suitable alternative to other medical interventions. (Intern Med J 2002; 32: 408−414)Keywords
This publication has 41 references indexed in Scilit:
- MANAGEMENT OF PARAPNEUMONIC EFFUSIONSClinics in Chest Medicine, 1998
- Serial Pleural Fluid Analysis in a New Experimental Model of EmpyemaChest, 1996
- A New Classification of Parapneumonic Effusions and EmpyemaChest, 1995
- Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.American Journal of Respiratory and Critical Care Medicine, 1995
- Management of Complicated Parapneumonic EffusionsAmerican Review of Respiratory Disease, 1993
- Intrapleural Streptokinase in Experimental EmpyemaAmerican Review of Respiratory Disease, 1993
- Abnormalities of Pathways of Fibrin Turnover in the Human Pleural SpaceAmerican Review of Respiratory Disease, 1991
- Use of purified streptokinase in empyema and hemothoraxThe American Journal of Surgery, 1991
- Immediate Drainage Is Not Required for All Patients with Complicated Parapneumonic EffusionsChest, 1990
- Parapneumonic Effusions and EmpyemaClinics in Chest Medicine, 1985